Aura Biosciences Inc (United States) is listed on the Nasdaq and has a market capitalization of $728.65 million, with shareholders equity totaling $315.27 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Aura Biosciences Inc reported $- in revenue, generating net income of $-131.02 million.
Key financial metrics include a P/E ratio of -5.56, a price-to-book (P/B) ratio of 2.31, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker AURA.